# Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade

> **NCT04435288** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Ghent** · enrollment: 90 (actual)

## Conditions studied

- Peripheral Spondyloarthritis

## Interventions

- **DRUG:** week 24
- **DRUG:** week 36
- **DRUG:** Week 48
- **DRUG:** Week 60

## Key facts

- **NCT ID:** NCT04435288
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-08-24
- **Primary completion:** 2025-05-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04435288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04435288, "Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04435288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*